These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3281808)

  • 21. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.
    Zietse R; Derkx FH; Weimar W; Schalekamp MA
    J Am Soc Nephrol; 1995 Jun; 5(12):2057-66. PubMed ID: 7579054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic nephropathy. Metabolic versus hemodynamic considerations.
    Hostetter TH
    Diabetes Care; 1992 Sep; 15(9):1205-15. PubMed ID: 1396017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of diabetic glomerulopathy: hemodynamic considerations.
    Hostetter TH
    Semin Nephrol; 1990 May; 10(3):219-27. PubMed ID: 2190279
    [No Abstract]   [Full Text] [Related]  

  • 24. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.
    Utimura R; Fujihara CK; Mattar AL; Malheiros DM; Noronha IL; Zatz R
    Kidney Int; 2003 Jan; 63(1):209-16. PubMed ID: 12472785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis.
    Hallow KM; Gebremichael Y; Helmlinger G; Vallon V
    Am J Physiol Renal Physiol; 2017 May; 312(5):F819-F835. PubMed ID: 28148531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
    Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R
    J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
    Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic factors in the pathogenesis of diabetic nephropathy.
    Schrier RW; Holzgreve H
    Klin Wochenschr; 1988 Apr; 66(8):325-31. PubMed ID: 3292819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
    Regolisti G; Buzio C; Cavatorta A; De Martin L; Cavalli R; Perazzoli F; Coghi P; Cabassi A; Pucci F; Borghetti A
    Acta Biomed Ateneo Parmense; 1992; 63(1-2):163-73. PubMed ID: 1340661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.
    Tikellis C; Brown R; Head GA; Cooper ME; Thomas MC
    Am J Physiol Renal Physiol; 2014 Apr; 306(7):F773-80. PubMed ID: 24477684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.
    Polichnowski AJ; Licea-Vargas H; Picken M; Long J; Bisla R; Williamson GA; Bidani AK; Griffin KA
    Am J Physiol Renal Physiol; 2015 Nov; 309(9):F791-9. PubMed ID: 26109088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
    Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
    Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats.
    Choi KC; Lee SC; Kim SW; Kim NH; Lee JU; Kang YJ
    Korean J Intern Med; 1999 Jan; 14(1):32-41. PubMed ID: 10063312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basement-membrane thickening and diabetic microangiopathy.
    Williamson JR; Kilo C
    Diabetes; 1976; 25(2 SUPPL):925-7. PubMed ID: 786763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial natriuretic peptide and glomerular hyperfiltration during onset of spontaneous diabetes mellitus.
    Okwueze MI; Opgenorth TJ; von Geldern TW; Vari RC
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R572-7. PubMed ID: 8141417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular haemodynamic profile of patients with Type 1 diabetes compared with healthy control subjects.
    Škrtić M; Lytvyn Y; Yang GK; Yip P; Lai V; Silverman M; Cherney DZ
    Diabet Med; 2015 Jul; 32(7):972-9. PubMed ID: 25662770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic benefit of converting-enzyme inhibition in progressive renal disease.
    Anderson S; Brenner BM
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):380S-383S. PubMed ID: 3056448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats.
    Luippold G; Beilharz M; Mühlbauer B
    Nephrol Dial Transplant; 2004 Feb; 19(2):342-7. PubMed ID: 14736957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion.
    Vervoort G; Veldman B; Berden JH; Smits P; Wetzels JF
    Eur J Clin Invest; 2005 May; 35(5):330-6. PubMed ID: 15860045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.